Patheon Revenue and Competitors
Estimated Revenue & Valuation
- Patheon's total funding is $200M.
Employee Data
- Patheon has 2665 Employees.
- Patheon grew their employee count by -3% last year.
Patheon's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Business Management | Reveal Email/Phone |
2 | VP, Business Services | Reveal Email/Phone |
3 | Head Quality Systems | Reveal Email/Phone |
4 | Head Analytical Sciences, Cell Therapy | Reveal Email/Phone |
5 | Head Calibration | Reveal Email/Phone |
6 | VP Human Resources and Public Relations | Reveal Email/Phone |
7 | SVP Global Engineering and Capacity Planning | Reveal Email/Phone |
8 | Director, Manufacturing Quality Assurance | Reveal Email/Phone |
9 | Director Pharmaceutics and Process Technology | Reveal Email/Phone |
10 | Director Legal Services | Reveal Email/Phone |
Patheon Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4180M | 14516 | 1% | $550M | $18.5B |
What Is Patheon?
Patheon is a leading global provider of contract dosage form development and manufacturing services to the pharmaceutical and biotechnology industries.Employing more than 4,700 highly-skilled staff, Patheon’s network of modern manufacturing facilities located in North America and Europe offer more than three million square feet (300,000 m2) of best in class capacity. With three facilities in the United States, three in Canada and four in Europe (including two in Italy, one in France and one in the United Kingdom) Patheon is able to meet the international requirements of its customers
keywords:N/A
$200M
Total Funding
2665
Number of Employees
N/A
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Patheon News
Bispecific Antibody Therapeutic Market Size, Share, Growth 2022 ... Blackswan Real Estate
Pharmaceutical Intermediates Consumption Market Share 2022 ... The New York Irish Emgirant
Global Pharmaceutical Intermediates Market 2022 Research ... Blackswan Real Estate
Grant comes to Patheon as the company adjusts its business strategy. Last year, the company announced a new corporate strategy that would evaluate its global footprint and cut costs. Those changes included closing some facilities. Meanwhile, Patheon is putting additional emphasis on its pharmace ...
“I am very gratified that Boehringer Ingelheim recognizes our expertise in formulating, scaling and successfully launching complex formulations such as these molecules,” Patheon President of Pharmaceutical Development Services and Chief Scientific Officer Mark Kontny said in a prepared statement ...
Other Companies in Durham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $887.3M | 3018 | 0% | N/A |
#2 | $773.8M | 3120 | 8% | $1.8M |
#3 | $735.5M | 3223 | 1% | N/A |
#4 | $2119.8M | 4659 | -1% | N/A |
#5 | $1227.2M | 4870 | 2% | N/A |